Literature DB >> 9526806

Consensus statement: Role of therapy with "statins" in patients with hypertriglyceridemia.

S M Grundy1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9526806     DOI： 10.1016/s0002-9149(98)00030-7

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


× No keyword cloud information.
  10 in total

Review 1.  Statin therapy and plasma free fatty acids: a systematic review and meta-analysis of controlled clinical trials.

Authors:  Amirhossein Sahebkar; Luis E Simental-Mendía; Claudio Pedone; Gianna Ferretti; Petr Nachtigal; Simona Bo; Giuseppe Derosa; Pamela Maffioli; Gerald F Watts
Journal:  Br J Clin Pharmacol       Date:  2016-02-02       Impact factor: 4.335

2.  Twenty questions on atherosclerosis.

Authors:  W C Roberts
Journal:  Proc (Bayl Univ Med Cent)       Date:  2000-04

3.  Lipoprotein-apheresis: Austrian consensus on indication and performance of treatment.

Authors:  Kurt Derfler; Sabine Steiner; Helmut Sinzinger
Journal:  Wien Klin Wochenschr       Date:  2015-07-23       Impact factor: 1.704

Review 4.  Lipaemia, inflammation and atherosclerosis: novel opportunities in the understanding and treatment of atherosclerosis.

Authors:  Antonie J H H M van Oostrom; Jeroen van Wijk; Manuel Castro Cabezas
Journal:  Drugs       Date:  2004       Impact factor: 9.546

Review 5.  The role of triglycerides in cardiovascular risk.

Authors:  Puneet Gandotra; Michael Miller
Journal:  Curr Cardiol Rep       Date:  2008-11       Impact factor: 2.931

6.  Effects of simvastatin, an HMG-CoA reductase inhibitor, in patients with hypertriglyceridemia.

Authors:  Jonathan Isaacsohn; Donald Hunninghake; Helmut Schrott; Carlos A Dujovne; Robert Knopp; Stuart R Weiss; Harold Bays; John R Crouse; Michael H Davidson; Leonard M Keilson; James McKenney; Stanley G Korenman; Adrian S Dobs; Evan Stein; Ronald M Krauss; Darbie Maccubbin; Meehyung Cho; Diane J Plotkin; Yale B Mitchel
Journal:  Clin Cardiol       Date:  2003-01       Impact factor: 2.882

7.  Adenosine and adenosine receptors: Newer therapeutic perspective.

Authors:  S Manjunath; Pranavkumar M Sakhare
Journal:  Indian J Pharmacol       Date:  2009-06       Impact factor: 1.200

8.  Long term efficacy and safety of atorvastatin in the treatment of severe type III and combined dyslipidaemia.

Authors:  M van Dam; M Zwart; F de Beer; A H M Smelt; M H Prins; M D Trip; L M Havekes; P J Lansberg; J J P Kastelein
Journal:  Heart       Date:  2002-09       Impact factor: 5.994

Review 9.  Molecular mechanisms underlying the effects of statins in the central nervous system.

Authors:  Amelia J McFarland; Shailendra Anoopkumar-Dukie; Devinder S Arora; Gary D Grant; Catherine M McDermott; Anthony V Perkins; Andrew K Davey
Journal:  Int J Mol Sci       Date:  2014-11-10       Impact factor: 5.923

10.  Simvastatin Treatment Upregulates HO-1 in Patients with Abdominal Aortic Aneurysm but Independently of Nrf2.

Authors:  Aleksandra Piechota-Polanczyk; Aleksandra Kopacz; Damian Kloska; Branislav Zagrapan; Christoph Neumayer; Anna Grochot-Przeczek; Ihor Huk; Christine Brostjan; Jozef Dulak; Alicja Jozkowicz
Journal:  Oxid Med Cell Longev       Date:  2018-03-20       Impact factor: 6.543
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.